| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424684000 | Aluminum silicate | 25 |
| 20080199539 | HEMOSTATIC COMPOSITIONS AND METHODS OF USE - Hemostatic compositions comprising a wet layered clay (e.g., wet kaolin) and, optionally, a zeolite, as well as devices and methods of use to promote blood clotting, are provided. | 08-21-2008 |
| 20080254146 | METHOD OF PROVIDING HEMOSTASIS IN ANTI-COAGULATED BLOOD - A method of clotting blood includes the step of administering a therapeutically effective amount of a composition comprising zeolite as the active ingredient to a wound from which the blood emanates. A method of arresting blood flowing from a wound includes the steps of providing a patient being inflicted with a bleeding wound and administering a therapeutically effective amount of a composition comprising zeolite as the active ingredient to the bleeding wound. A method of facilitating the formation of blood clots includes the step of contacting blood with a negatively charged surface wherein upon contacting the blood with the negatively charged surface a clotting mechanism is initiated. In any of the foregoing methods, the blood has a compromised ability to form clots. The blood may be from a person diagnosed with hemophilia or von Willebrand disease. | 10-16-2008 |
| 20080254147 | METHOD OF PROVIDING HEMOSTASIS IN ANTI-COAGULATED BLOOD - In a method of clotting blood in which the blood exhibits a reduced tendency to clot and may be from a person undergoing an anticoagulant therapy or having type A or B hemophilia or von Willebrand disease, a therapeutically effective amount of a composition comprising clay as the active ingredient is administered to a wound from which the blood emanates. Upon contacting the blood, this clay, which may be kaolin, bentonite, or any type of layered clay, causes the blood to clot. In a method of arresting blood flowing from a wound, a therapeutically effective amount of a composition comprising clay as the active ingredient is administered to the bleeding wound. In this method, the blood has a reduced tendency to clot and may be from a person undergoing an anticoagulant therapy or having at least one of hemophilia A or B or von Willebrand disease. | 10-16-2008 |
| 20080292730 | NUTRITIONAL SUPPLEMENT FOR OSTEOARTHRITIS - The present invention relates to a method of treating osteoarthritis by administering a mineral composition in the form of a nutritional supplement, where the mineral composition may contain Smectite, Gypsum, Quartz, Feldspar, Jarosite, Kaolinite and/or Zeolite. | 11-27-2008 |
| 20080311226 | Methods and Compositions For Improving Stool Quality - A method for improving stool quality by administering to an animal a composition comprising from about 1% to about 20% zeolite. Preferably, the zeolite is fed to ah animal as part of a food composition containing least one ingredient suitable for consumption by an animal. | 12-18-2008 |
| 20090047366 | Inorganic Coagulation Accelerators for Individuals taking Platelet Blockers or Anticoagulants - The present invention is a method to accelerate the coagulation of blood through the application of inorganic materials to the wound of a patient on anticoagulant or platelet blocker therapy. The method comprises contacting such wounds with a substance selected from the group consisting of zeolitic molecular sieves and non-zeolitic molecular sieves, diatomaceous earth, glass powder or fibers, precipitated or fumed silica, kaolin and montmorillonite clays and Ca exchanged permutites. | 02-19-2009 |
| 20090104286 | REGULATION OF ALLERGIC REACTION - After the analysis of 21 genes which are involved in the inflammatory processes of a mouse, it was shown that, among other things, the featured preparations strongly activate NFkB and its translocation from cytoplasm into the nucleus in spleen cells. Besides that, by activation of relb genes, the featured preparations shift the balance of Th1/Th2 in the direction of Th1 so that it stimulates recruiting of Th0 into Th1 and their multiplication. The featured preparations regulate the activity of clonally selected B lymphocytes, so that selective promoters, such as, e.g., IFNγ and IL-10, stimulate the coding of molecules of the heavy chain of Ig and the production of IgG in the fight against allergens. The preparations are thus used for prevention of allergic reactions and have an immunoregulatory function when the symptoms of allergic reactions are already present. | 04-23-2009 |
| 20090117206 | Preservative and Additive for Food and Feed - A preservative and additive for food and feed. One aspect of the invention concerns various acidified clays and minerals as food or feed additive to kill, or inhibit the growth of, harmful microorganisms and to inactivate mycotoxins, such as aflatoxins, present as contaminants in human foods and animal feeds. Another aspect of the present invention relates to a clay of hydrated sodium calcium aluminosilicate with relatively uniform particle size distribution. | 05-07-2009 |
| 20090297632 | Device, Methods and Compositions to Alter Light Interplay with Skin - Device, methods, and compositions to alter light interplay with skin to change appearance of wrinkles, pigmentation, stretch marks, and cellulite as well as other skin conditions are described. The present invention relates generally to the treatment of soft tissue volume deficiency and loss, facial wrinkles, facial lines, pigmentation patterns not desired by the subject, stretch marks, cellulite and more particularly, to treatments for volume restoration or coloration correction using light reflective materials such as micas and the like. | 12-03-2009 |
| 20100129472 | Compositions And Method For The Treatment Of Acne - The present invention relates to methods for the treatment and reduction of acne and compositions comprising sulfur colloid and a 100% natural base. | 05-27-2010 |
| 20100143501 | SOLID COMPOSITION COMPRISING A CLAY SUCH AS KAOLIN - The present invention relates to a therapeutic composition comprising at least one clay, at least one disintegrant, at least one lubricant and at least one binding agent, particularly wherein the at least one clay is kaolin, and in particular to a palatable clay composition in the form of a tablet, and to a process for the preparation of the therapeutic composition | 06-10-2010 |
| 20100173015 | COMPOSITIONS AND METHODS FOR THE ABSORPTION, CHELATION, AND ELIMINATION OF TRACE ELEMENTS - This invention relates to compositions and methods effective for the absorption, chelation and elimination of trace elements, in particular tin, mercury, aluminium, cadmium, lead, and other metals, metaloids and lanthinides. It is comprised of dihydroquercetin and zeolite, with or without humic and fulvic acids. The combination acts as a powerful chelator and eliminator of toxic trace elements and enhances their absorption from the intestine, blood, and organs, and may be administered for the absorption, chelation and elimination of toxic or potentially toxic trace elements including metals and metalloids, and lanthinides. | 07-08-2010 |
| 20100173016 | COMPOSITIONS AND METHODS FOR THE ABSORPTION, CHELATION, AND ELIMINATION OF TRACE METALS - This invention relates to compositions and methods effective for the absorption, chelation and elimination of trace elements, in particular tin, mercury, aluminium, cadmium, lead, and other metals, metaloids and lanthinides. It is comprised of dihydroquercetin and zeolite, with or without humic and fulvic acids. The combination acts as a powerful chelator and eliminator of toxic trace elements and enhances their absorption from the intestine, blood, and organs, and may be administered for the absorption, chelation and elimination of toxic or potentially toxic trace elements including metals and metalloids, and lanthinides. | 07-08-2010 |
| 20100196515 | External Preparation For Skin - The present invention provides an external preparation for skin comprising antibacterial zeolite and a nonvolatile liquid oil component that comprises a nonionic surfactant having a HLB of 6-8 that has a polyoxyethylene chain. | 08-05-2010 |
| 20100227005 | METHODS TO TREAT AND/OR PREVENT MUCOSITIS - The present invention relates to methods useful for treating and/or preventing mucositis using an active vitamin D compound. | 09-09-2010 |
| 20110229588 | METHOD FOR THE REDUCTION OF THE CONCENTRATION OF AMINES AND SALTS THEREOF - The invention relates to a method for reducing the concentration of amines and salts thereof, wherein the amines have the general chemical formula I R1R2R3N and the salts have the formula II R1R2R3N—H, wherein the amines and salts thereof exist in aqueous solution or aqueous suspension and are brought into contact with clinoptilolitic or clinoptilolite-containing mixtures. The method itself is suitable for use in food preparation and in the manufacture of foods. The inventive idea of reducing the concentration of amines and salts thereof is also useful in the manufacture of medical products for absorbing and for removing amines from the intestinal tract or the skin area of humans and animals. | 09-22-2011 |
| 20120045526 | PHARMACEUTICAL COMPOUND WHICH INCLUDES CLINOPTILOLITE - This invention is for a compound for treating a human or animal body to relieve the symptoms of any one of chemical-, substance-, and medicine induced gastrointestinal tract irritation, the compound including clinoptilolite. The invention is also for a compound for treating a human or animal body to lower the incidences of gastic events in persons using non-steroidal, anti-inflammatory medications, the compound including clinoptilolite. | 02-23-2012 |
| 20120201905 | W/O Emulsion Cosmetics - The present invention provides a W/O emulsion cosmetic excellent in the feeling in use and stability. The W/O emulsion cosmetic of the present invention comprises the following components (A) to (F): (A) 0.1 to 5 mass % of polyoxyalkylene/alkyl-comodified silicone; (B) polyoxyalkylene-modified silicone, being 0.2 to 3 times in mass with respect to the component (A); (C) 5 to 50 mass % of powder; (D) 10 to 50 mass % of a volatile oil; (E) 1 to 20 mass % of ethanol; and (F) water. In addition, the dispersion stability of powder and viscosity stability of the composition can be improved, by further blending sodium glutamate or by further blending an organically modified clay mineral and diglyceryl diisostearate therein. Furthermore, if glycerin and a specific nonvolatile oil are blended therein, the moisturizing property can be improved. | 08-09-2012 |
| 20130059016 | CLAY COMPOSITIONS - The present invention relates to liquid or semi-solid pharmaceutical compositions, more specifically to aqueous pharmaceutical suspension or semi-solid paste containing natural mineral clays as active ingredients. These compositions are particularly useful for the treatment of acute and chronic diarrhea. | 03-07-2013 |
| 20130243887 | ZEOLITES HAVING A NEURO-PROTECTIVE EFFECT - The present invention relates to the preparation of zeolites obtained with a method comprising a stage of heating to temperature preferably of over 400° C. and at least one stage of micronisation. Such zeolites are to be used in the pharmaceutical sector, in particular to combat the action of ROS at a mitochondrial level with a neuroprotective effect. | 09-19-2013 |
| 20130309325 | COMPOSITION AND METHOD FOR PROMOTING JOINT AND BONE HEALTH - The present invention provides compositions comprising silicon and at least one other joint health ingredient such as glucosamine, chondroitin, hyaluronic acid, collage, etc. as well as methods for making and using the same. | 11-21-2013 |
| 20140030362 | MINERAL BASED COMPOSITION AND METHODS OF USE - The invention provides a process for producing a composition comprising natural alumino-silicate minerals having improved reactivity for use in methods of animal husbandry, veterinary and pharmaceutical treatment, comprising irradiating natural alumino-silicate minerals in a liquid suspension with transverse electromagnetic wave radiation in the range of 1,800 MHz to 3,000 MHz, the liquid suspension having a boiling temperature of below 120° C. The invention also provides a method of treating digestive ailments in animals comprising administering to an animal in need of same an effective amount of a composition comprising at least one natural alumina-silicate mineral which has been irradiated with transverse electromagnetic wave radiation in the range of 1,800 MHz to 3,000 MHz. | 01-30-2014 |
| 20140044804 | METHODS AND COMPOSITIONS FOR SELECTIVELY REMOVING POTASSIUM ION FROM THE GASTROINTESTINAL TRACT OF A MAMMAL - The present invention provides methods and compositions for the treatment of ion imbalances using core-shell composites and compositions comprising such core-shell composites. In particular, the invention provides core-shell particles and compositions comprising potassium binding polymers, and core-shell particles and compositions comprising sodium binding polymers, and in each case, pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are also disclosed. The compositions and methods of the invention offer improved approaches for treatment of hyperkalemia and other indications related to potassium ion homeostasis, and for treatment of hypertension and other indicates related to sodium ion homeostasis. | 02-13-2014 |
| 20140057000 | PREVENTION OR TREATMENT OF PAINFUL POLYNEUROPATHIES BY ADMINISTRATION OF AN ALUMINOSILICATE - The invention relates to the prevention or treatment of painful polyneuropathies caused by toxic agents, i.e. to the prevention, reduction or elimination of the symptoms associated with such polyneuropathies, such as neuropathic pain. The invention provides an aluminosilicate for use in such prevention or treatment, preferably a natural or synthetic zeolite, such as clinoptilolite. The toxic agent is, in particular, a chemotherapeutic cytotoxic agent. | 02-27-2014 |
| 20140072658 | Antioxidant Composition - The present invention relates to a new class of anitoxidant agent comprising a pharmaceutically acceptable silicate, resveratrol, grape seeds extract, green tea extract and tomato powder. In particular this composition comprises between 32 to 60 percent by weight of a pharmaceutically acceptable silicate, between 6 to 22 percent by weight of resveratrol, between 16 to 20 percent by weight of grape seeds extract, between 8 to 10 percent by weight of green tea extract, and between 10 to 16 percent by weight of tomato powder. | 03-13-2014 |
